Fluorine in PDB 6fex: DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4%
Enzymatic activity of DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4%
All present enzymatic activity of DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4%:
2.7.10.1;
Protein crystallography data
The structure of DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4%, PDB code: 6fex
was solved by
M.Stihle,
H.Richter,
J.Benz,
B.Kuhn,
M.G.Rudolph,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
60.47 /
1.29
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
40.834,
61.750,
63.072,
90.00,
106.51,
90.00
|
R / Rfree (%)
|
13.7 /
17.4
|
Other elements in 6fex:
The structure of DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4% also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4%
(pdb code 6fex). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the
DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4%, PDB code: 6fex:
Jump to Fluorine binding site number:
1;
2;
3;
Fluorine binding site 1 out
of 3 in 6fex
Go back to
Fluorine Binding Sites List in 6fex
Fluorine binding site 1 out
of 3 in the DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4%
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4% within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1001
b:14.4
occ:1.00
|
F14
|
A:D6Z1001
|
0.0
|
14.4
|
1.0
|
C13
|
A:D6Z1001
|
1.3
|
14.5
|
1.0
|
F15
|
A:D6Z1001
|
2.1
|
16.4
|
1.0
|
F16
|
A:D6Z1001
|
2.1
|
16.7
|
1.0
|
C12
|
A:D6Z1001
|
2.3
|
14.9
|
1.0
|
H43
|
A:D6Z1001
|
2.6
|
17.9
|
1.0
|
HE2
|
A:HIS764
|
2.8
|
11.9
|
1.0
|
N11
|
A:D6Z1001
|
2.9
|
14.2
|
1.0
|
HA
|
A:ALA783
|
2.9
|
10.1
|
1.0
|
O
|
A:ALA783
|
2.9
|
10.1
|
1.0
|
HB2
|
A:ASP784
|
3.0
|
13.7
|
1.0
|
C
|
A:ALA783
|
3.0
|
9.4
|
1.0
|
HG22
|
A:ILE782
|
3.2
|
15.6
|
1.0
|
HD2
|
A:HIS764
|
3.2
|
11.2
|
1.0
|
H44
|
A:D6Z1001
|
3.2
|
17.9
|
1.0
|
NE2
|
A:HIS764
|
3.3
|
9.9
|
1.0
|
H42
|
A:D6Z1001
|
3.3
|
17.1
|
1.0
|
CA
|
A:ALA783
|
3.4
|
8.4
|
1.0
|
CD2
|
A:HIS764
|
3.5
|
9.3
|
1.0
|
N
|
A:ASP784
|
3.6
|
9.4
|
1.0
|
C9
|
A:D6Z1001
|
3.6
|
12.8
|
1.0
|
CB
|
A:ASP784
|
3.7
|
11.4
|
1.0
|
HB3
|
A:ASP784
|
3.7
|
13.7
|
1.0
|
O10
|
A:D6Z1001
|
3.7
|
13.1
|
1.0
|
O
|
A:ILE782
|
3.8
|
10.7
|
1.0
|
N
|
A:ALA783
|
3.8
|
8.8
|
1.0
|
C
|
A:ILE782
|
4.0
|
10.3
|
1.0
|
H
|
A:ASP784
|
4.0
|
11.3
|
1.0
|
CG2
|
A:ILE782
|
4.1
|
13.0
|
1.0
|
CA
|
A:ASP784
|
4.2
|
10.8
|
1.0
|
HG23
|
A:ILE684
|
4.3
|
15.6
|
1.0
|
H
|
A:ALA783
|
4.3
|
10.5
|
1.0
|
HG21
|
A:ILE782
|
4.4
|
15.6
|
1.0
|
CE1
|
A:HIS764
|
4.5
|
10.9
|
1.0
|
HA
|
A:ASP784
|
4.5
|
13.0
|
1.0
|
HD11
|
A:LEU757
|
4.6
|
13.9
|
1.0
|
HB
|
A:ILE782
|
4.7
|
13.3
|
1.0
|
HG23
|
A:ILE782
|
4.7
|
15.6
|
1.0
|
H41
|
A:D6Z1001
|
4.7
|
14.1
|
1.0
|
CG
|
A:HIS764
|
4.8
|
10.0
|
1.0
|
CB
|
A:ALA783
|
4.8
|
10.1
|
1.0
|
C8
|
A:D6Z1001
|
4.8
|
11.7
|
1.0
|
HE2
|
A:PHE762
|
4.9
|
22.9
|
1.0
|
CB
|
A:ILE782
|
4.9
|
11.1
|
1.0
|
O
|
A:HOH1274
|
4.9
|
25.9
|
1.0
|
HB1
|
A:ALA783
|
4.9
|
12.2
|
1.0
|
HE1
|
A:HIS764
|
4.9
|
13.2
|
1.0
|
HB
|
A:ILE685
|
5.0
|
16.4
|
1.0
|
HD12
|
A:ILE684
|
5.0
|
17.3
|
1.0
|
HD13
|
A:LEU679
|
5.0
|
19.2
|
1.0
|
CG
|
A:ASP784
|
5.0
|
14.9
|
1.0
|
|
Fluorine binding site 2 out
of 3 in 6fex
Go back to
Fluorine Binding Sites List in 6fex
Fluorine binding site 2 out
of 3 in the DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4%
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4% within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1001
b:16.4
occ:1.00
|
F15
|
A:D6Z1001
|
0.0
|
16.4
|
1.0
|
C13
|
A:D6Z1001
|
1.3
|
14.5
|
1.0
|
F14
|
A:D6Z1001
|
2.1
|
14.4
|
1.0
|
F16
|
A:D6Z1001
|
2.2
|
16.7
|
1.0
|
C12
|
A:D6Z1001
|
2.3
|
14.9
|
1.0
|
H44
|
A:D6Z1001
|
2.6
|
17.9
|
1.0
|
H43
|
A:D6Z1001
|
2.6
|
17.9
|
1.0
|
HG23
|
A:ILE684
|
3.1
|
15.6
|
1.0
|
HD13
|
A:LEU679
|
3.2
|
19.2
|
1.0
|
HD11
|
A:LEU757
|
3.3
|
13.9
|
1.0
|
HD2
|
A:HIS764
|
3.3
|
11.2
|
1.0
|
HD11
|
A:LEU679
|
3.6
|
19.2
|
1.0
|
N11
|
A:D6Z1001
|
3.6
|
14.2
|
1.0
|
HD21
|
A:LEU757
|
3.7
|
15.2
|
1.0
|
HG21
|
A:ILE684
|
3.7
|
15.6
|
1.0
|
CG2
|
A:ILE684
|
3.8
|
13.0
|
1.0
|
HD12
|
A:ILE684
|
3.8
|
17.3
|
1.0
|
CD1
|
A:LEU679
|
3.8
|
16.0
|
1.0
|
HE2
|
A:PHE762
|
3.8
|
22.9
|
1.0
|
H42
|
A:D6Z1001
|
4.0
|
17.1
|
1.0
|
CD2
|
A:HIS764
|
4.0
|
9.3
|
1.0
|
HD13
|
A:LEU757
|
4.1
|
13.9
|
1.0
|
HG22
|
A:ILE782
|
4.1
|
15.6
|
1.0
|
CD1
|
A:LEU757
|
4.1
|
11.6
|
1.0
|
HG22
|
A:ILE684
|
4.1
|
15.6
|
1.0
|
HD12
|
A:LEU679
|
4.1
|
19.2
|
1.0
|
HE2
|
A:HIS764
|
4.3
|
11.9
|
1.0
|
HD22
|
A:LEU757
|
4.3
|
15.2
|
1.0
|
O
|
A:ILE782
|
4.4
|
10.7
|
1.0
|
CD2
|
A:LEU757
|
4.4
|
12.6
|
1.0
|
CE2
|
A:PHE762
|
4.4
|
19.1
|
1.0
|
HA
|
A:ALA783
|
4.5
|
10.1
|
1.0
|
NE2
|
A:HIS764
|
4.5
|
9.9
|
1.0
|
C9
|
A:D6Z1001
|
4.6
|
12.8
|
1.0
|
HB
|
A:ILE782
|
4.7
|
13.3
|
1.0
|
CD1
|
A:ILE684
|
4.7
|
14.4
|
1.0
|
HB2
|
A:ASP784
|
4.7
|
13.7
|
1.0
|
HD12
|
A:LEU757
|
4.8
|
13.9
|
1.0
|
HG21
|
A:ILE782
|
4.8
|
15.6
|
1.0
|
O10
|
A:D6Z1001
|
4.8
|
13.1
|
1.0
|
CG2
|
A:ILE782
|
4.8
|
13.0
|
1.0
|
CG
|
A:LEU757
|
4.9
|
11.3
|
1.0
|
HD22
|
A:LEU679
|
4.9
|
19.2
|
1.0
|
C
|
A:ILE782
|
4.9
|
10.3
|
1.0
|
O
|
A:ALA783
|
4.9
|
10.1
|
1.0
|
HD2
|
A:PHE762
|
5.0
|
19.4
|
1.0
|
HZ
|
A:PHE762
|
5.0
|
23.1
|
1.0
|
|
Fluorine binding site 3 out
of 3 in 6fex
Go back to
Fluorine Binding Sites List in 6fex
Fluorine binding site 3 out
of 3 in the DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4%
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of DDR1, 2-[4-Bromo-2-Oxo-1'-(1H-Pyrazolo[4,3-B]Pyridine-5-Carbonyl) Spiro[Indole-3,4'-Piperidine]-1-Yl]-N-(2,2,2-Trifluoroethyl) Acetamide, 1.291A, P212121, Rfree=17.4% within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1001
b:16.7
occ:1.00
|
F16
|
A:D6Z1001
|
0.0
|
16.7
|
1.0
|
C13
|
A:D6Z1001
|
1.3
|
14.5
|
1.0
|
F14
|
A:D6Z1001
|
2.1
|
14.4
|
1.0
|
F15
|
A:D6Z1001
|
2.2
|
16.4
|
1.0
|
C12
|
A:D6Z1001
|
2.3
|
14.9
|
1.0
|
H42
|
A:D6Z1001
|
2.6
|
17.1
|
1.0
|
H44
|
A:D6Z1001
|
2.7
|
17.9
|
1.0
|
N11
|
A:D6Z1001
|
2.8
|
14.2
|
1.0
|
HB2
|
A:ASP784
|
3.2
|
13.7
|
1.0
|
H43
|
A:D6Z1001
|
3.3
|
17.9
|
1.0
|
HE2
|
A:PHE762
|
3.3
|
22.9
|
1.0
|
O
|
A:HOH1238
|
3.5
|
44.5
|
1.0
|
O
|
A:HOH1274
|
3.6
|
25.9
|
1.0
|
HD2
|
A:HIS764
|
3.6
|
11.2
|
1.0
|
HB3
|
A:ASP784
|
3.6
|
13.7
|
1.0
|
HZ
|
A:PHE762
|
3.8
|
23.1
|
1.0
|
CD2
|
A:HIS764
|
3.9
|
9.3
|
1.0
|
CB
|
A:ASP784
|
3.9
|
11.4
|
1.0
|
HE2
|
A:HIS764
|
3.9
|
11.9
|
1.0
|
CE2
|
A:PHE762
|
4.0
|
19.1
|
1.0
|
C9
|
A:D6Z1001
|
4.0
|
12.8
|
1.0
|
NE2
|
A:HIS764
|
4.0
|
9.9
|
1.0
|
CZ
|
A:PHE762
|
4.2
|
19.2
|
1.0
|
HD11
|
A:LEU679
|
4.2
|
19.2
|
1.0
|
HD13
|
A:LEU679
|
4.5
|
19.2
|
1.0
|
OD2
|
A:ASP784
|
4.6
|
18.6
|
1.0
|
O
|
A:ALA783
|
4.6
|
10.1
|
1.0
|
O10
|
A:D6Z1001
|
4.7
|
13.1
|
1.0
|
HA
|
A:HIS764
|
4.7
|
10.9
|
1.0
|
C
|
A:ALA783
|
4.7
|
9.4
|
1.0
|
CG
|
A:HIS764
|
4.7
|
10.0
|
1.0
|
CD1
|
A:LEU679
|
4.8
|
16.0
|
1.0
|
HA
|
A:ALA783
|
4.8
|
10.1
|
1.0
|
CG
|
A:ASP784
|
4.8
|
14.9
|
1.0
|
HD11
|
A:LEU757
|
4.8
|
13.9
|
1.0
|
N
|
A:ASP784
|
4.8
|
9.4
|
1.0
|
H41
|
A:D6Z1001
|
4.9
|
14.1
|
1.0
|
HD12
|
A:LEU679
|
4.9
|
19.2
|
1.0
|
CE1
|
A:HIS764
|
4.9
|
10.9
|
1.0
|
HG22
|
A:ILE782
|
5.0
|
15.6
|
1.0
|
C8
|
A:D6Z1001
|
5.0
|
11.7
|
1.0
|
CA
|
A:ASP784
|
5.0
|
10.8
|
1.0
|
|
Reference:
H.Richter,
A.L.Satz,
M.Bedoucha,
B.Buettelmann,
A.C.Petersen,
A.Harmeier,
R.Hermosilla,
R.Hochstrasser,
D.Burger,
B.Gsell,
R.Gasser,
S.Huber,
M.N.Hug,
B.Kocer,
B.Kuhn,
M.Ritter,
M.G.Rudolph,
F.Weibel,
J.Molina-David,
J.J.Kim,
J.V.Santos,
M.Stihle,
G.J.Georges,
R.D.Bonfil,
R.Fridman,
S.Uhles,
S.Moll,
C.Faul,
A.Fornoni,
M.Prunotto.
Dna-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in A Genetic Mouse Model of Alport Syndrome. Acs Chem.Biol. V. 14 37 2019.
ISSN: ESSN 1554-8937
PubMed: 30452219
DOI: 10.1021/ACSCHEMBIO.8B00866
Page generated: Thu Aug 1 20:07:29 2024
|